Navigation Links
Hoya Vision Care Expands in Czech Republic
Date:8/21/2008

UITHOORN, the Netherlands, August 21 /PRNewswire-FirstCall/ -- Hoya Corporation's Vision Care Division, a key player in the global market for ophthalmic lenses, announced today that it acquired Dioptra CZ a.s., one of the leading distributors of ophthalmic lenses in the Czech Republic.

Dioptra has a long and rich tradition in the optical field, with origins dating back to 1896. Hoya and Dioptra have worked together under an exclusive arrangement since the year 2000. Dioptra CZ employs 32 people in Turnov, near Prague, and generated over EUR 4 million sales in 2007.

Hoya Corporation's Vision Care Division will acquire 100 percent of the shares in Dioptra CZ. While the existing management team will remain in place, Mr. Rainer Burkard, Director of Global Business Development for Hoya Vision Care, will serve as Acting Managing Director thru 2008.

In early 2009, Hoya expects to appoint Ms. Ivana Nechanicka to serve as Managing Director of Dioptra CZ. Ms. Nechanicka is currently the Southwest Regional Sales Manager for Hoya Vision Care North America. A Czech native and consistently one of Hoya's top sales producers, Ms. Nechanicka will return to her homeland after living in the U.S. for 35 years.

The agreement with Dioptra CZ will allow Hoya to increase sales of high-end premium products in the fast-growing Czech market. Hoya believes the Czech market is growing in excess of 10% per year, driven by an accelerated conversion of mineral to organic lenses, and bi-focal to progressive designs.

Gerald W. Bottero, President and CEO of Hoya Vision Care, said: "We are excited about the future of Hoya in the Czech market, and expect to see higher sales of progressive lenses due to rising disposable incomes, a highly educated class of eye care professionals and favourable demographic trends."

About Hoya Corporation

Hoya Corporation is a global leader in information technology, eye care, medical devices and imaging systems. With over 35,000 employees and operations across the globe, Hoya recorded total sales of over JPY 481.6 billion in fiscal year 2007. Hoya was founded in 1941 and trades on the First Section of the Tokyo Stock Exchange.


'/>"/>
SOURCE Hoya Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Hooper Holmes Heritage Labs Division Launches New Home Diabetes Test
2. Principle of Recursive Genome Function Supersedes Dogmas; By Andras Pellionisz, Online Ahead of Print; (Scientific Visionary Vindicated)
3. RTXC Kernel Awareness Module from Quadros Systems Now Available for Keil Vision Debugger
4. Stallergenes: Q2 2008 Sales up 18% Revision Upwards of 2008 Sales Growth
5. NovaVision Appoints Medical Technology Veteran Rudy Mazzocchi as Chief Executive Officer
6. Environmental Tectonics Corporations BioMedical Systems Division Awarded Contract for Multiple Monoplace Chambers
7. Atrium completes the sale of its Active Ingredients and Specialty Chemicals division
8. Environmental Tectonics Corporations BioMedical Division Announces Sale of Two Hyperbaric Chambers
9. Ocular Biopharmaceutical Company Charlesson Announces $1.6MM in New Funding and Upcoming Presentations at The Association for Research in Vision and Ophthalmology
10. Boston Scientific and Surgi-Vision Announce Licensing Agreement for MRI-Safe Technology
11. Molecular Vision and Acrongenomics Unable to Reach Agreement on the Acquisition of Molecular Vision
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... NC (PRWEB) , ... June 27, 2016 , ... ... mission to bring innovative medical technologies, services and solutions to the healthcare market. ... and implementation of various distribution, manufacturing, sales and marketing strategies that are necessary ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
Breaking Biology Technology:
(Date:6/21/2016)... 2016 NuData Security announced today that Randy ... principal product architect and that Jon Cunningham ... development. Both will report directly to Christopher ... reflect NuData,s strategic growth in its product and ... demand and customer focus values. ...
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/9/2016)...  Perkotek an innovation leader in attendance control systems is proud to announce the ... employers to make sure the right employees are actually signing in, and to even ... ... ... ...
Breaking Biology News(10 mins):